Search for author "A. Michael Lincoff"

• Open Access

  Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective

  C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington

  Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687

  View table

  Table 6.

  By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington

  Cholesterol Efflux, HDL Cholesterol, and ApoA-I Values Immediately After Infusion of CSL112Show More

  Cholesterol Efflux, HDL Cholesterol, and ApoA-I Values Immediately After Infusion of CSL112Show Less
• You have accessRestricted access

  Abstract 16033: A Paradoxical Relationship of Plasma Adiponectin to Cardiovascular Risk in Patients With Diabetes and Recent Acute Coronary Syndrome - the Alecardio Trial

  Ilse C Schrieks, Anna Nozza, Barbara E Stähli, John B Buse, Klas Malmberg, Bruce Neal, Stephan J Nicholls, Lars Rydén, Anders Svensson, Hans Wedel, Arlette Weichert, A. Michael Lincoff, Jean-Claude Tardif, Diederick E Grobbee and Gregory G Schwartz

  Circulation. 2016;134:A16033
• You have accessRestricted access

  Abstract 20280: Impact of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib on Cholesterol Efflux Capacity in High Risk Patients Within the ACCELERATE Trial

  Giacomo Ruotolo, Michael A Lincoff, Steven E Nissen, Venugopal Menon, Jeffrey S Riesmeyer, Lauren Beacham, Ellen McErlean, Daniel J Rader and Stephen J Nicholls

  Circulation. 2016;134:A20280
• You have accessRestricted access

  Abstract 5598: Angiographic Evidence of Early Coronary Artery Disease and Inceased Risk of Mortality in Smokers with Non-ST-Segment Elevation Acute Coronary Syndromes: An Analysis of the ACUITY Trial

  Jason O Robertson, Ramin Ebrahimi, Alexandra J Lansky, Roxana Mehran, Gregg W Stone and A M Lincoff

  Circulation. 2008;118:S_971
• You have accessRestricted access

  Abstract 4589: Anti-thrombotic Strategies in Patients with Elevated Biomarkers Undergoing PCI: Results from the ACUITY Trial

  Somjot S Brar, Brent T McLaurin, David A Cox, Michel E Bertrand, A. Michael Lincoff, Jeffrey W Moses, Harvey D White, E Magnus Ohman, Roxana Mehran, Alexandra Lansky, Helen Parise and Gregg W Stone

  Circulation. 2008;118:S_917
• You have accessRestricted access

  Abstract 2001: Clinical and Angiographic Predictors of 30-Day and One-Year Ischemic Cardiac Events in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An ACUITY Substudy

  Kenji Goto, Alexandra Lansky, Ecatarina Cristea, Michel E Bertrand, A. Michael Lincoff, Jeffrey W Moses, Martin Fahy, Roxana Mehran and Gregg W Stone

  Circulation. 2008;118:S_654
• You have access

  Abstract 2001: Clinical and Angiographic Predictors of 30-Day and One-Year Ischemic Cardiac Events in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An ACUITY Substudy

  Kenji Goto, Alexandra Lansky, Ecatarina Cristea, Michel E Bertrand, A. Michael Lincoff, Jeffrey W Moses, Martin Fahy, Roxana Mehran, Gregg W Stone

  Circulation October 2008, 118 (Suppl 18) S_654;

  

  Table 7:

  By Kenji Goto, Alexandra Lansky, Ecatarina Cristea, Michel E Bertrand, A. Michael Lincoff, Jeffrey W Moses, Martin Fahy, Roxana Mehran and Gregg W Stone

  Multivariate Predictors of Composite IschemiaShow More

  Multivariate Predictors of Composite IschemiaShow Less
• You have accessRestricted access

  Abstract 15083: Precise Etiology of Death within 30 days of Percutaneous Coronary Intervention in an era of Mandatory Outcome Reporting

  Bhuvnesh Aggarwal, Stephen G Ellis, Michael A Lincoff, Samir R Kapadia, Joseph Cacchione, Russell E Raymond, Leslie Cho, Christopher Bajzer, Ravi Nair, Irving Franco, Conrad Simpfendorfer, E M Tuzcu, Patrick L Whitlow and Mehdi H Shishehbor

  Circulation. 2012;126:A15083
• You have accessRestricted access

  Abstract 849: Aleglitazar, a Balanced Peroxisome Proliferator-Activated Receptor (PPAR)α/γ Agonist, Provides Beneficial Effects on Cardiovascular Markers of Inflammation and Clotting

  Robert R Henry, A Michael Lincoff, Sunder Mudaliar, Cathy Chognot, Michael Rabbia and Matthias Herz

  Circulation. 2009;120:S404
• You have access

  Abstract 849: Aleglitazar, a Balanced Peroxisome Proliferator-Activated Receptor (PPAR)α/γ Agonist, Provides Beneficial Effects on Cardiovascular Markers of Inflammation and Clotting

  Robert R Henry, A Michael Lincoff, Sunder Mudaliar, Cathy Chognot, Michael Rabbia, Matthias Herz

  Circulation November 2009, 120 (Suppl 18) S404;

  

  By Robert R Henry, A Michael Lincoff, Sunder Mudaliar, Cathy Chognot, Michael Rabbia and Matthias Herz

  Show More

  Show Less

Pages